Key Points
- EVP Bryant Yates sold 11,968 shares of Nature's Sunshine Products at an average price of $19.90, totaling about $238,163. After the sale, he still owned 77,446 shares, reducing his stake by 13.38%.
- The stock was down slightly, opening at $20.40, with the company carrying a market cap of about $358.6 million and a P/E ratio of 18.55.
- Nature's Sunshine recently beat quarterly expectations, reporting $0.30 EPS versus the $0.20 consensus and revenue of $122.89 million, while analysts currently rate the stock a Moderate Buy with a $35 average price target.
Nature's Sunshine Products, Inc. (NASDAQ:NATR - Get Free Report) EVP Bryant Yates sold 11,968 shares of the firm's stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $19.90, for a total transaction of $238,163.20. Following the completion of the transaction, the executive vice president directly owned 77,446 shares of the company's stock, valued at approximately $1,541,175.40. The trade was a 13.38% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Nature's Sunshine Products Stock Down 0.3%
Shares of Nature's Sunshine Products stock opened at $20.40 on Friday. Nature's Sunshine Products, Inc. has a 52-week low of $12.97 and a 52-week high of $28.14. The company has a 50 day moving average of $23.84 and a 200 day moving average of $23.81. The company has a market capitalization of $358.63 million, a P/E ratio of 18.55 and a beta of 0.86.
Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.20 by $0.10. Nature's Sunshine Products had a net margin of 4.06% and a return on equity of 14.67%. The company had revenue of $122.89 million during the quarter, compared to the consensus estimate of $122.15 million.
Analyst Upgrades and Downgrades
NATR has been the topic of a number of recent research reports. Canaccord Genuity Group set a $37.00 target price on shares of Nature's Sunshine Products in a report on Friday, May 8th. DA Davidson reaffirmed a "buy" rating and issued a $33.00 target price on shares of Nature's Sunshine Products in a report on Monday, May 11th. Finally, Weiss Ratings cut shares of Nature's Sunshine Products from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $35.00.
Check Out Our Latest Stock Report on Nature's Sunshine Products
Hedge Funds Weigh In On Nature's Sunshine Products
Institutional investors have recently bought and sold shares of the company. Hillsdale Investment Management Inc. increased its stake in Nature's Sunshine Products by 107.9% in the 3rd quarter. Hillsdale Investment Management Inc. now owns 170,804 shares of the company's stock valued at $2,651,000 after buying an additional 88,657 shares during the period. Aristides Capital LLC increased its stake in Nature's Sunshine Products by 11.4% in the 4th quarter. Aristides Capital LLC now owns 40,907 shares of the company's stock valued at $883,000 after buying an additional 4,184 shares during the period. Punch & Associates Investment Management Inc. boosted its position in shares of Nature's Sunshine Products by 9.0% during the 4th quarter. Punch & Associates Investment Management Inc. now owns 340,000 shares of the company's stock worth $7,337,000 after purchasing an additional 28,000 shares in the last quarter. Kemnay Advisory Services Inc. purchased a new stake in shares of Nature's Sunshine Products during the 4th quarter worth $201,000. Finally, Clearstead Advisors LLC boosted its position in shares of Nature's Sunshine Products by 16,025.0% during the 4th quarter. Clearstead Advisors LLC now owns 1,935 shares of the company's stock worth $42,000 after purchasing an additional 1,923 shares in the last quarter. 79.40% of the stock is owned by institutional investors and hedge funds.
Nature's Sunshine Products Company Profile
(
Get Free Report)
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
